Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
Cadamuro M, Nardo G, Indraccolo S, Dall'olmo L, Sambado L, Moserle L, Franceschet I, Colledan M, Massani M, Stecca T, Bassi N, Morton S, Spirli C, Fiorotto R, Fabris L, Strazzabosco M. Cadamuro M, et al. Hepatology. 2013 Sep;58(3):1042-53. doi: 10.1002/hep.26384. Epub 2013 Jul 22. Hepatology. 2013. PMID: 23505219 Free PMC article.
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, Fingas C, Cristina Malerba M, Nardo G, Dall'Olmo L, Milani E, Mariotti V, Stecca T, Massani M, Spirli C, Fiorotto R, Indraccolo S, Strazzabosco M, Fabris L. Cadamuro M, et al. J Hepatol. 2019 Apr;70(4):700-709. doi: 10.1016/j.jhep.2018.12.004. Epub 2018 Dec 14. J Hepatol. 2019. PMID: 30553841 Free PMC article.
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.
Fabris L, Cadamuro M, Moserle L, Dziura J, Cong X, Sambado L, Nardo G, Sonzogni A, Colledan M, Furlanetto A, Bassi N, Massani M, Cillo U, Mescoli C, Indraccolo S, Rugge M, Okolicsanyi L, Strazzabosco M. Fabris L, et al. Among authors: cadamuro m. Hepatology. 2011 Sep 2;54(3):890-9. doi: 10.1002/hep.24466. Hepatology. 2011. PMID: 21618579 Free PMC article.
Animal models of cholangiocarcinoma: What they teach us about the human disease.
Cadamuro M, Brivio S, Stecca T, Kaffe E, Mariotti V, Milani C, Fiorotto R, Spirli C, Strazzabosco M, Fabris L. Cadamuro M, et al. Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):403-415. doi: 10.1016/j.clinre.2018.04.008. Epub 2018 May 9. Clin Res Hepatol Gastroenterol. 2018. PMID: 29753731 Review.
Precision medicine in cholangiocarcinoma.
Pellino A, Loupakis F, Cadamuro M, Dadduzio V, Fassan M, Guido M, Cillo U, Indraccolo S, Fabris L. Pellino A, et al. Among authors: cadamuro m. Transl Gastroenterol Hepatol. 2018 Jul 12;3:40. doi: 10.21037/tgh.2018.07.02. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 30148225 Free PMC article. Review.
Cholangiocarcinoma.
Sarcognato S, Sacchi D, Fassan M, Fabris L, Cadamuro M, Zanus G, Cataldo I, Capelli P, Baciorri F, Cacciatore M, Guido M. Sarcognato S, et al. Among authors: cadamuro m. Pathologica. 2021 Jun;113(3):158-169. doi: 10.32074/1591-951X-252. Pathologica. 2021. PMID: 34294934 Free PMC article. Review.
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
Olaizola P, Lee-Law PY, Fernandez-Barrena MG, Alvarez L, Cadamuro M, Azkargorta M, O'Rourke CJ, Caballero-Camino FJ, Olaizola I, Macias RIR, Marin JJG, Serrano-Maciá M, Martinez-Chantar ML, Avila MA, Aspichueta P, Calvisi DF, Evert M, Fabris L, Castro RE, Elortza F, Andersen JB, Bujanda L, Rodrigues PM, Perugorria MJ, Banales JM. Olaizola P, et al. Among authors: cadamuro m. J Hepatol. 2022 Jul;77(1):177-190. doi: 10.1016/j.jhep.2022.02.007. Epub 2022 Feb 23. J Hepatol. 2022. PMID: 35217064 Free article.
79 results